A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)

NCT01419028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2019-04-01

Study results available
· View outcomes & findings →

Summary

This study aims to characterize the natural history of patients with severe perinatal or infantile onset HPP.

Conditions

  • Hypophosphatasia (HPP)

Sponsors & Collaborators

  • Alexion Pharmaceuticals, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-06-30
Completion
2014-02-28

Countries

  • United States
  • Australia
  • Canada
  • Germany
  • Spain
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419028 on ClinicalTrials.gov